The latest on managing care, value-based care, insurance markets, payers & providers

Headlines On Deadline ...

About 1 in 6 Americans report paying more than 10 percent of their total family income for health insurance premiums, says the latest report from the Agency for Healthcare Research and Quality. Of those with employer-sponsored insurance, 16 percent spend 10 percent or more of their income on premiums and out-of-pocket expenses. Of those with public insurance, 16 percent spend 10 percent or more of their income on out-of-pocket expenses (and 84 percent do not).… Advising adult patients to get vaccinated for the flu, especially during the 2009–2010 pandemic, would seem to make a lot of sense. But a study in Preventive Medicine suggests that 64 percent of adults did not receive any provider-issued influenza vaccination recommendation. Adults who were advised to get vaccinated were 14.1 to 32.1 percentage points more likely to get vaccinated than adults who did not receive a recommendation…. A merger between Medco and Sanofi will help the French drug manufacturer navigate the American payer and regulatory landscape. Sanofi’s research and development will benefit from the merger, gaining a perspective on the views of health insurers and governments that are seeking evidence of a drug’s demonstrated benefits before paying for it. Sanofi will benefit from Medco’s voluminous claims data, which it collects by providing pharmacy benefits to millions. Medco will be a consultant to the drugmaker on comparative studies for both experimental and approved drugs.

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

  • Doug Jones and the ACA, Epic misses a White House meeting, and man caves for man-flu sufferers
  • CVS-Aetna deal may trigger merger mania, Johns Hopkins criticized for lack of asthma prevention, & Columbia sees free-ride future for all of its med students

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.